1. Effect of walnut consumption on neuropsychological development in healthy adolescents: a multi-school randomised controlled trial
- Author
-
Universitat Rovira i Virgili, Pinar-Martí, A; Gignac, F; Fernández-Barrés, S; Romaguera, D; Sala-Vila, A; Lázaro, I; Ranzani, OT; Persavento, C; Delgado, A; Carol, A; Torrent, J; Gonzalez, J; Roso, E; Barrera-Gómez, J; López-Vicente, M; Boucher, O; Nieuwenhuijsen, M; Turner, MC; Burgaleta, M; Canals, J; Arija, V; Basagaña, X; Ros, E; Salas-Salvadó, J; Sunyer, J; Julvez, J, Universitat Rovira i Virgili, and Pinar-Martí, A; Gignac, F; Fernández-Barrés, S; Romaguera, D; Sala-Vila, A; Lázaro, I; Ranzani, OT; Persavento, C; Delgado, A; Carol, A; Torrent, J; Gonzalez, J; Roso, E; Barrera-Gómez, J; López-Vicente, M; Boucher, O; Nieuwenhuijsen, M; Turner, MC; Burgaleta, M; Canals, J; Arija, V; Basagaña, X; Ros, E; Salas-Salvadó, J; Sunyer, J; Julvez, J
- Abstract
Background: Omega-3 fatty acids are critical for neuropsychological functioning. Adolescence is increasingly believed to entail brain vulnerability to dietary intake. The potential benefit on adolescent neurodevelopment of consuming walnuts, a source of omega-3 alpha-linolenic acid (ALA), remains unclear. Methods: We conducted a 6-month multi-school-based randomised controlled nutrition intervention trial to assess whether walnut consumption has beneficial effects on the neuropsychological and behavioural development of adolescents. The study took place between 04/01/2016 and 06/30/2017 in twelve different high schools in Barcelona, Spain (ClinicalTrials.gov Identifier: NCT02590848). A total of 771 healthy teenagers aged 11–16 years were randomised into two equal groups (intervention or control). The intervention group received 30 g/day of raw walnut kernels to be incorporated into their diet for 6 months. Multiple primary endpoints concerning neuropsychological (working memory, attention, fluid intelligence, and executive function) and behavioural (socio-emotional and attention deficit hyperactivity disorder [ADHD] symptoms) development were assessed at baseline and after intervention. Red blood cell (RBC) ALA status was determined at baseline and 6 months as a measure of compliance. Main analyses were based on intention-to-treat using a linear mixed-effects model. A per-protocol effect of the intervention was analysed using inverse-probability weighting to account for post-randomisation prognostic factors (including adherence) using generalised estimating equations. Findings: In intention-to-treat analyses, at 6 months there were no statistically significant changes between the intervention and control groups for all primary endpoints. RBC ALA (%) significantly increa
- Published
- 2023